Department of Pediatrics, Yale School of Medicine, New Haven, CT.
Division of Pulmonary and Critical Care, Department of Medicine, Intermountain Medical Center, University of Utah, Murray, UT.
Crit Care Med. 2019 May;47(5):706-714. doi: 10.1097/CCM.0000000000003699.
Previous studies report worse short-term outcomes with hypoglycemia in critically ill children. These studies relied on intermittent blood glucose measurements, which may have introduced detection bias. We analyzed data from the Heart And Lung Failure-Pediatric INsulin Titration trial to determine the association of hypoglycemia with adverse short-term outcomes in critically ill children.
Nested case-control study.
Thirty-five PICUs. A computerized algorithm that guided the timing of blood glucose measurements and titration of insulin infusion, continuous glucose monitors, and standardized glucose infusion rates were used to minimize hypoglycemia.
Nondiabetic children with cardiovascular and/or respiratory failure and hyperglycemia. Cases were children with any hypoglycemia (blood glucose < 60 mg/dL), whereas controls were children without hypoglycemia. Each case was matched with up to four unique controls according to age group, study day, and severity of illness.
None.
A total of 112 (16.0%) of 698 children who received the Heart And Lung Failure-Pediatric INsulin Titration protocol developed hypoglycemia, including 25 (3.6%) who developed severe hypoglycemia (blood glucose < 40 mg/dL). Of these, 110 cases were matched to 427 controls. Hypoglycemia was associated with fewer ICU-free days (median, 15.3 vs 20.2 d; p = 0.04) and fewer hospital-free days (0 vs 7 d; p = 0.01) through day 28. Ventilator-free days through day 28 and mortality at 28 and 90 days did not differ between groups. More children with insulin-induced versus noninsulin-induced hypoglycemia had zero ICU-free days (35.8% vs 20.9%; p = 0.008). Outcomes did not differ between children with severe versus nonsevere hypoglycemia or those with recurrent versus isolated hypoglycemia.
When a computerized algorithm, continuous glucose monitors and standardized glucose infusion rates were used to manage hyperglycemia in critically ill children with cardiovascular and/or respiratory failure, severe hypoglycemia (blood glucose < 40 mg/dL) was uncommon, but any hypoglycemia (blood glucose < 60 mg/dL) remained common and was associated with worse short-term outcomes.
既往研究报告称,危重症患儿发生低血糖会导致短期预后更差。这些研究依赖于间歇性血糖测量,这可能引入了检测偏倚。我们分析了心肺衰竭-儿科胰岛素滴定试验的数据,以确定危重症患儿低血糖与不良短期结局的关系。
巢式病例对照研究。
35 个 PICUs。使用计算机算法指导血糖测量时间、胰岛素输注滴定、连续血糖监测仪和标准化葡萄糖输注率,以尽量减少低血糖的发生。
心血管和/或呼吸衰竭且伴有高血糖的非糖尿病患儿。病例为出现任何程度低血糖(血糖 < 60mg/dL)的患儿,而对照组为无低血糖的患儿。每个病例根据年龄组、研究日和疾病严重程度与多达 4 个独特的对照相匹配。
无。
在接受心肺衰竭-儿科胰岛素滴定方案的 698 名患儿中,共有 112 名(16.0%)发生了低血糖,其中 25 名(3.6%)发生了严重低血糖(血糖 < 40mg/dL)。其中,110 例病例与 427 例对照相匹配。与对照组相比,低血糖患儿 ICU 无天数(中位数,15.3 与 20.2d;p=0.04)和住院无天数(0 与 7d;p=0.01)更少。两组患儿在 28 天内的呼吸机无天数和 28 天及 90 天死亡率无差异。与非胰岛素诱导低血糖相比,胰岛素诱导低血糖患儿 ICU 无天数更多(35.8% 与 20.9%;p=0.008)。严重低血糖与非严重低血糖患儿或反复性低血糖与非反复性低血糖患儿的结局无差异。
在使用计算机算法、连续血糖监测仪和标准化葡萄糖输注率治疗伴有心血管和/或呼吸衰竭的危重症患儿高血糖时,严重低血糖(血糖 < 40mg/dL)少见,但任何程度的低血糖(血糖 < 60mg/dL)仍很常见,并与短期预后更差相关。